Redx Pharma
Redx Pharma Logo
About Redx Pharma
Redx Pharma Ltd is a clinical-stage biotechnology company specializing in the discovery and development of novel, small molecule, targeted medicines for fibrotic diseases, cancer, and cancer-associated fibrosis. Leveraging expertise in medicinal chemistry and translational science, Redx Pharma has advanced a portfolio of differentiated compounds, including RXC008 for fibrostenotic Crohn's disease, DDR inhibitors for chronic kidney disease, zelasudil (RXC007) for interstitial lung diseases, and zamaporvint (RXC004) for Wnt-ligand driven cancers. The company aims to deliver best-in-class or first-in-class treatments for diseases with unmet medical need.
Year founded
2010
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
